Groesbeck Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$559K Sell
1,545
-28
-2% -$9.59K 0.89% 27
2026
Q1
$553K Buy
1,573
+13
+0.8% +$4.63K 1.08% 29
2025
Q4
$511K Buy
1,560
+5
+0.3% +$1.59K 0.96% 31
2025
Q3
$439K Buy
1,555
+63
+4% +$18.3K 0.86% 35
2025
Q2
$417K Sell
1,492
-295
-17% -$83.6K 0.73% 39
2025
Q1
$557K Sell
1,787
-267
-13% -$78.8K 0.78% 44
2024
Q4
$535K Sell
2,054
-750
-27% -$223K 0.7% 46
2024
Q3
$903K Sell
2,804
-600
-18% -$196K 1.33% 24
2024
Q2
$1.06M Sell
3,404
-399
-10% -$117K 1.47% 20
2024
Q1
$1.08M Buy
3,803
+15
+0.4% +$4.39K 1.15% 26
2023
Q4
$1.09M Buy
3,788
+200
+6% +$54.5K 1.51% 22
2023
Q3
$964K Buy
3,588
+230
+7% +$57.4K 1.46% 21
2023
Q2
$746K Sell
3,358
-437
-12% -$101K 1.14% 30
2023
Q1
$917K Hold
3,795
1.37% 23
2022
Q4
$997K Sell
3,795
-32
-0.8% -$8.58K 1.67% 17
2022
Q3
$931K Hold
3,827
1.54% 18
2022
Q2
$931K Sell
3,827
-146
-4% -$35.8K 1.54% 18
2022
Q1
$961K Hold
3,973
1.08% 26
2021
Q4
$894K Buy
3,973
+210
+6% +$44.3K 1.14% 28
2021
Q3
$800K Sell
3,763
-635
-14% -$146K 0.92% 34
2021
Q2
$1.07M Buy
4,398
+524
+14% +$129K 1.37% 24
2021
Q1
$964K Buy
3,874
+350
+10% +$83.5K 1.39% 23
2020
Q4
$810K Sell
3,524
-116
-3% -$26.7K 1.33% 25
2020
Q3
$925K Hold
3,640
1.73% 16
2020
Q2
$859K Sell
3,640
-198
-5% -$45.2K 1.7% 19
2020
Q1
$778K Sell
3,838
-15,050
-80% -$3.29M 2.09% 10
2019
Q4
$4.55M Sell
18,888
-486
-3% -$107K 3.36% 8
2019
Q3
$3.75M Buy
19,374
+924
+5% +$177K 2.81% 8
2019
Q2
$3.4M Sell
18,450
-104
-0.6% -$18.6K 2.76% 7
2019
Q1
$3.52M Sell
18,554
-241
-1% -$46K 2.69% 10
2018
Q4
$3.66M Sell
18,795
-406
-2% -$79.2K 3.12% 7
2018
Q3
$3.98M Sell
19,201
-347
-2% -$68.4K 2.7% 9
2018
Q2
$3.61M Sell
19,548
-222
-1% -$39.3K 2.52% 10
2018
Q1
$3.37M Sell
19,770
-5,100
-21% -$936K 2.44% 13
2017
Q4
$4.33M Sell
24,870
-697
-3% -$123K 3.04% 9
2017
Q3
$4.77M Sell
25,567
-175
-0.7% -$31K 3.43% 4
2017
Q2
$4.43M Sell
25,742
-527
-2% -$85.7K 3.28% 5
2017
Q1
$4.31M Sell
26,269
-428
-2% -$71.1K 3.2% 7
2016
Q4
$3.9M Sell
26,697
-396
-1% -$59.6K 3.05% 9
2016
Q3
$4.52M Sell
27,093
-6,108
-18% -$1.03M 3.35% 4
2016
Q2
$5.05M Sell
33,201
-221
-0.7% -$34.4K 3.69% 3
2016
Q1
$5.01M Sell
33,422
-1,751
-5% -$260K 3.59% 6
2015
Q4
$5.71M Sell
35,173
-692
-2% -$109K 3.64% 4
2015
Q3
$4.96M Sell
35,865
-1,413
-4% -$223K 3.13% 7
2015
Q2
$5.72M Buy
37,278
+1,944
+6% +$311K 2.74% 9
2015
Q1
$5.65M Sell
35,334
-1,652
-4% -$260K 2.74% 9
2014
Q4
$5.89M Sell
36,986
-2,244
-6% -$350K 2.89% 7
2014
Q3
$5.51M Sell
39,230
-4,558
-10% -$595K 2.62% 8
2014
Q2
$5.18M Sell
43,788
-788
-2% -$91.2K 2.26% 14
2014
Q1
$5.5M Buy
44,576
+9,513
+27% +$1.15M 2.47% 14
2013
Q4
$4M Buy
35,063
+6,669
+23% +$759K 1.66% 27
2013
Q3
$3.18M Sell
28,394
-2,504
-8% -$272K 1.38% 35
2013
Q2
$3.05M Buy
+30,898
New +$3.21M 1.29% 37

Other funds holding AMGN

Groesbeck Investment Management's AMGN Position: Q2 2026 in Review

Groesbeck Investment Management reduced its Amgen (AMGN) stake by 1.8% in Q2 2026, selling an estimated $9.59K and leaving 1,545 shares worth $559K. The position accounts for 0.89% of the portfolio, ranked #27.

Groesbeck Investment Management first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.89M in Q4 2014. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Groesbeck Investment Management held 1,545 shares of Amgen worth $559K as of Q2 2026.
  • Groesbeck Investment Management sold 28 Amgen shares in Q2 2026, an estimated $9.59K.
  • Amgen made up 0.89% of Groesbeck Investment Management's portfolio in Q2 2026, its #27 holding.
  • Groesbeck Investment Management first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Groesbeck Investment Management's Amgen position peaked at $5.89M in Q4 2014.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Groesbeck Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.